These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35230707)

  • 1. Arrest of progression and duration to achieve it: an important indicator for efficacy of medication aimed at rapidly progressive vitiligo.
    Patra S; Khaitan BK
    Int J Dermatol; 2022 Jul; 61(7):e245-e246. PubMed ID: 35230707
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study.
    Bishnoi A; Vinay K; Kumaran MS; Parsad D
    Arch Dermatol Res; 2021 Jul; 313(5):357-365. PubMed ID: 32737577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo.
    Kanwar AJ; Mahajan R; Parsad D
    J Cutan Med Surg; 2013; 17(4):259-68. PubMed ID: 23815959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the editor: "Oral mini-pulse therapy in vitiligo: A systematic review".
    Chavez-Alvarez S; Herz-Ruelas M; Raygoza-Cortez AK; Suro-Santos Y; Ocampo-Candiani J; Alvarez-Villalobos NA; Villarreal-Martinez A
    Int J Dermatol; 2022 Jul; 61(7):e246-e247. PubMed ID: 35239974
    [No Abstract]   [Full Text] [Related]  

  • 5. A rational approach to the treatment of vitiligo and other hypomelanoses.
    Hercogová J; Buggiani G; Prignano F; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesylate-induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors.
    Han H; Yu YY; Wang YH
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S80-3. PubMed ID: 19119132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo development in a patient with psoriasis vulgaris treated with ixekizumab.
    Eker H; Kaya İslamoğlu ZG; Demirbaş A
    Dermatol Ther; 2022 Apr; 35(4):e15314. PubMed ID: 35019197
    [No Abstract]   [Full Text] [Related]  

  • 8. A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo.
    Singh H; Kumaran MS; Bains A; Parsad D
    Dermatology; 2015; 231(3):286-90. PubMed ID: 26278124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral minocycline in the treatment of vitiligo--a preliminary study.
    Parsad D; Kanwar A
    Dermatol Ther; 2010; 23(3):305-7. PubMed ID: 20597950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients.
    Kim SM; Lee HS; Hann SK
    Int J Dermatol; 1999 Jul; 38(7):546-50. PubMed ID: 10440289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early localized vitiligo, a medical emergency: Long-term follow-up study.
    Esmat SM; Bassiouny D; Hegazy R; Shalaby S; Ragab N; Ibrahim S; Mogawer RM
    Dermatol Ther; 2022 Feb; 35(2):e15219. PubMed ID: 34812544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of experimental autoimmune vitiligo by oral administration of mushroom tyrosinase.
    Zehtab T; Yazdanparast R; Rafieii S
    Cytobios; 2001; 105(408):27-34. PubMed ID: 11368265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cyclosporine is effective in stabilizing active vitiligo: Results of a randomized controlled trial.
    Mehta H; Kumar S; Parsad D; Bishnoi A; Vinay K; Kumaran MS
    Dermatol Ther; 2021 Sep; 34(5):e15033. PubMed ID: 34151493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease.
    Pasricha JS; Khaitan BK
    Int J Dermatol; 1993 Oct; 32(10):753-7. PubMed ID: 8225724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus: nephritis, dilated cardiomyopathy, and extensive cutaneous depigmentation responsive to hydroxychloroquine.
    Walsh DS; Farley MF; Beard JS; Sau P; Tesar J; James WD
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):828-30. PubMed ID: 7593787
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo.
    Seiter S; Ugurel S; Tilgen W; Reinhold U
    Int J Dermatol; 2000 Aug; 39(8):624-7. PubMed ID: 10971735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oral simvastatin in the treatment of patients with vitiligo.
    Zhang S; Zdravković TP; Wang T; Liu Y; Jin H
    J Investig Med; 2021 Feb; 69(2):393-396. PubMed ID: 33093072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral dexamethasone pulse treatment for vitiligo.
    Radakovic-Fijan S; Fürnsinn-Friedl AM; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2001 May; 44(5):814-7. PubMed ID: 11312430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease.
    Pasricha JS; Khera V
    Int J Dermatol; 1994 Aug; 33(8):584-7. PubMed ID: 7960359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the outcome measures used in clinical trials for vitiligo.
    Br J Dermatol; 2023 Feb; 188(2):e17. PubMed ID: 36763883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.